Intravenous immunoglobulin (IVIG)is a blood product administered intravenously. These are mainly used for the treatment of immune deficiencies, autoimmune diseases and acute infections. IVIG is given as a plasma protein replacement therapy for immune deficient patients (i.e. patients have decreased or abolished antibody productions). Intravenous immunoglobulin is administered to maintain sufficient antibody levels of a patient in order to prevent infections or to enhance immunity. There are different intravenous immunoglobulinproducts availableas trade names in the market namely Gamunex, Flebogamma,Gammagard and Privigen.








Browse Full Report : http://www.transparencymarketresearch.com/intravenous-immunoglobulin-market.html

The global intravenous immunoglobulin market is witnessing high growth due to growing geriatricpopulation, rising health expenditure and increasing number of patients with bleeding disorder. In addition,the market of intravenous immunoglobulinproducts is also witnessing positive growth owing to increasing number of patients suffering from autoimmune diseases, asthma and other pathological conditions coupled with risinguse of IVIG. Technological advancements and introduction of new improved therapies for the treatment of these diseases will further propel the growth of this market. However, side effects such as dermatitis, acute kidney injury and venous thrombosis with the use of IVIG, high cost of treatment and stringent restrains the market growth.

Geographically, North America dominates the global intravenous immunoglobulin marketdue to increasing patient population suffering from autoimmune diseases, asthma and other diseases.Europe is considered as the second largest market of intravenous immunoglobulin due to increasing aging population. According to Eurostat (European Commission) report published in 2013, around 17.8% of the European population were 65 years and above. In addition, Asia-Pacific countries are the emerging nationsfor the global intravenous immunoglobulinmarket due to increasing healthcare awareness among the patient population.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1930


Some of the major players operating in this marketincludeBaxter International Inc., Bharat Serums and Vaccines Ltd., Biotest AG,CSL Limited, Grifols S.A., Octapharma AG, OMRIX Biopharmaceuticals Ltd, Kedrion S.p.A and others.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/